Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares traded down 4.4% on Friday . The company traded as low as $15.60 and last traded at $15.62. 3,839 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 18,023 shares. The stock had previously closed at $16.34.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on TLX shares. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company.
Check Out Our Latest Stock Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Trading Down 3.2 %
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- About the Markup Calculator
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Best Stocks Under $10.00
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
